Sign In
Buy MRSN
$29.08
+0 (+0%)
At Close: Apr 02, 2026
At Virtual MTT-S IMS 2020, Teledyne Showcases Dual-Channel DACs, Track & Hold Amps, Digitizer Studio Software, 90GHz Connectors
12:00am, Monday, 03'rd Aug 2020
Teledyne Technologies is featuring a broad range of advanced RF & Microwave products and capabilities this week at the annual International Microw
Mersana Therapeutics to Host Conference Call Announcing Second Quarter 2020 Financial Results and Business Updates
12:00pm, Friday, 31'st Jul 2020
CAMBRIDGE, Mass., July 31, 2020 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-dr
Immunogen: Q2 Earnings Insights
12:00am, Friday, 31'st Jul 2020
Shares of Immunogen (NASDAQ:IMGN) moved higher by 3.0% in pre-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share were up 51.72% over the...
ADC asks Lai to give details of re-looted funds - TheCable
11:30pm, Wednesday, 29'th Jul 2020
The African Democratic Congress (ADC) has asked Lai Mohammed, minister of information and culture, to declare the percentage of re-looted assets.
Biotech Bonanza - Second Half Outlook
08:24am, Tuesday, 28'th Jul 2020
Biotech is one of the rare industries whose prospects have improved as the year has progressed. A low interest rate environment, a less hostile regulatory environment, and strong investor interest cre
Ondo 2020: Akeredolu's kinsman, Adelegan, emerges ADC guber candidate - Businessday NG
09:48am, Sunday, 26'th Jul 2020
The African Democratic Congress (ADC), on Saturday expressed optimism that it would win the forthcoming October 10, governorship...
Daiichi Sankyo and Gustave Roussy Enter Innovative Research Collaboration for DXd ADCs DS-1062 and Patritumab Deruxtecan
12:00am, Wednesday, 22'nd Jul 2020
Daiichi Sankyo and Gustave Roussy enter innovative research collaboration for DXd ADCs DS-1062 and patritumab deruxtecan (U3-1402).
Analysts Expect Mersana Therapeutics Inc (NASDAQ:MRSN) Will Announce Quarterly Sales of $430,000.00
02:12am, Sunday, 19'th Jul 2020
Analysts forecast that Mersana Therapeutics Inc (NASDAQ:MRSN) will report $430,000.00 in sales for the current quarter, Zacks reports. Two analysts have provided estimates for Mersana Therapeutics’
Mersana Therapeutics Sees Unusually Large Options Volume (NASDAQ:MRSN)
01:36am, Sunday, 19'th Jul 2020
Mersana Therapeutics Inc (NASDAQ:MRSN) was the recipient of some unusual options trading on Friday. Stock investors bought 3,140 call options on the stock. This is an increase of 711% compared to the
Advisor Group Holdings Inc. Takes Position in Agree Realty Co. (NYSE:ADC)
10:54pm, Wednesday, 15'th Jul 2020
Advisor Group Holdings Inc. purchased a new stake in shares of Agree Realty Co. (NYSE:ADC) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The
Edo2020: Nollywood Actress, Mabel Oboh, Emerges ADC Governorship Candidate | Naija News
06:50pm, Wednesday, 15'th Jul 2020
The African Democratic Congress (ADC) has picked the Nollywood actress Princess Mabel Oboh as its candidate for the Edo State gubernatorial elections scheduled for September 19, 2020.
Nollywood actress, Mabel Oboh, emerges ADC guber candidate in Edo - Vanguard News
01:12pm, Tuesday, 14'th Jul 2020
ADC has announced Nollywood actress and veteran broadcaster, Princess Mabel Oboh as its candidate for the Edo gubernatorial elections
Government must stop England's children becoming long-term victims of Covid-19 | Jenny Coles
01:01pm, Tuesday, 14'th Jul 2020
The social toll of coronavirus on young people could be devastating unless children’s services get the funding they need
Parametric Portfolio Associates LLC Has $85,000 Stock Holdings in Mersana Therapeutics Inc (NASDAQ:MRSN)
05:42am, Tuesday, 14'th Jul 2020
Parametric Portfolio Associates LLC increased its holdings in Mersana Therapeutics Inc (NASDAQ:MRSN) by 9.5% in the first quarter, according to its most recent Form 13F filing with the Securities and
Capital One Financial Analysts Reduce Earnings Estimates for Agree Realty Co. (NYSE:ADC)
01:50am, Monday, 13'th Jul 2020
Agree Realty Co. (NYSE:ADC) – Equities research analysts at Capital One Financial dropped their Q2 2020 EPS estimates for Agree Realty in a research report issued on Thursday, July 9th. Capital One
